Over the last 10 years, left ventricular assist devices (LVADs) have proved to be a viable alternative to heart transplants. The procedure gives patients a chance to experience a better overall quality of life, especially those who are not candidates for heart transplant.
The University of Michigan Frankel Cardiovascular Center is home to one of the world’s largest and most experienced LVAD programs. In fact, U-M’s LVAD program has successfully implanted more than 580 long-term devices in patients.
One man’s journey with the HeartMate II LVAD
One of those is David Pierce, who has the distinguished recognition as being the longest living HeartMate II LVAD patient in the U.S. David received his first LVAD on May 26, 2004, at the age of 52. Today, he is living a happy, healthy life — and spending precious time with his family.